Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the latest advancements in cancer treatment modalities, including chemotherapy, radiotherapy, and surgical interventions. Participants will explore novel therapeutic approaches and their implications for patient outcomes.
This session emphasizes the importance of translational research in oncology, highlighting how laboratory discoveries can be effectively applied to clinical settings. Discussions will include case studies that demonstrate successful translation of research findings into therapeutic strategies.
This track will delve into the evolving landscape of immunotherapy, examining the mechanisms of action and clinical applications of immune checkpoint inhibitors and CAR T-cell therapies. Experts will discuss challenges and opportunities in enhancing patient responses.
Focusing on the role of genomics and molecular profiling, this session will explore how precision medicine is transforming cancer treatment paradigms. Attendees will learn about personalized therapeutic strategies tailored to individual patient profiles.
This track investigates the underlying biological mechanisms of tumor development and progression, with a focus on identifying novel therapeutic targets. Researchers will present findings that could lead to innovative treatment options.
This session addresses the critical aspects of patient care in oncology, including symptom management, psychosocial support, and survivorship issues. Discussions will highlight strategies to enhance the quality of life for cancer patients and their families.
This track examines the intersection of health policy and oncology, focusing on the implications of policy decisions on cancer care delivery and access to treatment. Participants will engage in discussions about advocacy and the role of policy in shaping cancer research funding.
This session will explore the impact of emerging technologies, such as artificial intelligence and telemedicine, on cancer diagnosis and treatment. Experts will discuss how these innovations can improve patient outcomes and streamline clinical workflows.
Focusing on the design and implementation of clinical trials in oncology, this track will cover best practices and innovative methodologies. Researchers will share insights on overcoming challenges in trial execution and patient recruitment.
This session will address the specific challenges faced in pediatric oncology, including treatment protocols and long-term effects of therapy. Experts will discuss recent advances in the field and the importance of tailored approaches for young patients.
This track highlights international collaborations and research initiatives aimed at addressing cancer disparities worldwide. Participants will explore how global partnerships can enhance cancer research and improve outcomes in diverse populations.
